Results 21 to 30 of about 443,505 (210)

Temporal Shift of the Respiratory Syncytial Virus Epidemic Peak for the Years 2020–2023 in Marseille, Southern France

Viruses, 2023
Respiratory syncytial virus is among the most common causes of respiratory infections. Typically, this viral infection has a seasonality during the cold months but with the SARS-CoV-2 pandemic this has been considerably modified.
Lucille Claire De Maria, Philippe Colson, Aurélie Morand, Noémie Vanel, Didier Stoupan, Bernard La Scola, Céline Boschi   +6 more
doaj   +1 more source

Molecular characterization of circulating respiratory syncytial virus (RSV) genotypes in Gilgit Baltistan Province of Pakistan during 2011-2012 winter season. [PDF]

PLoS ONE, 2013
Respiratory syncytial virus (RSV) is the major cause of acute lower respiratory tract infections in young children, but very little is known about its epidemiology and circulating genotypes in Pakistan.
Uzma Bashir, Muhammad Masroor Alam, Hajra Sadia, Syed Sohail Zahoor Zaidi, Birjees Mazher Kazi   +4 more
doaj   +1 more source

Epidemic dynamics of respiratory syncytial virus in current and future climates

Nature Communications, 2019
Climate affects dynamics of infectious diseases, but the impact on respiratory syncytial virus (RSV) epidemiology isn’t well understood. Here, Baker et al.
Rachel E. Baker, Ayesha S. Mahmud, Caroline E. Wagner, Wenchang Yang, Virginia E. Pitzer, Cecile Viboud, Gabriel A. Vecchi, C. Jessica E. Metcalf, Bryan T. Grenfell   +8 more
doaj   +1 more source

The incidence and clinical burden of respiratory syncytial virus disease identified through hospital outpatient presentations in Kenyan children [PDF]

, 2012
There is little information that describe the burden of respiratory syncytial virus (RSV) associated disease in the tropical African outpatient setting. Methods We studied a systematic sample of children aged
Bett, Ann, Okiro Emelda A., D James Nokes, Ann Bett, Bett Ann, Emelda A Okiro, Ngama Mwanajuma, Nokes D. James, Nokes, D. James, Mwanajuma Ngama, Ngama, Mwanajuma, Okiro, Emelda A.   +11 more
core   +1 more source

Risk factors for hospital admission with RSV bronchiolitis in England: a population-based birth cohort study. [PDF]

, 2014
OBJECTIVE: To examine the timing and duration of RSV bronchiolitis hospital admission among term and preterm infants in England and to identify risk factors for bronchiolitis admission.
Paul Aylin (355512), Aylin, P, Sonia Saxena, Murray, J, Bottle, A, Bottle Alex, Joanna Murray, Paul Aylin, Saxena, S, Sonia Saxena (258806), Medicines for Neonates Investigator Group, Alex Bottle, Azeem Majeed (69210), Aylin Paul, Modi, N, Alex Bottle (258808), Sharland Mike, Majeed, A, Majeed Azeem, Mike Sharland (258810), Saxena Sonia, Neena Modi, Modi Neena, Mike Sharland, Joanna Murray (527948), Neena Modi (527789), Sharland, M, Azeem Majeed, Murray Joanna, Majeed, Azeem, Petrou, Stavros, Young, Annie M., Costeloe, Kate, Bottle, Alex, Modi, N., Modi, Neena, Brocklehurst, Peter, Saxena, Sonia, Abbott, J., Draper, E. S., Ashby, Deborah, Aylin, Paul, Kemp, J., Sharland, Mike, Murray, Joanna   +44 more
core   +1 more source

Risk factors for respiratory syncytial virus bronchiolitis hospital admission in New Zealand. [PDF]

, 2008
This study assessed risk factors for respiratory syncytial virus (RSV) hospitalization and disease severity in Wellington, New Zealand. During the southern hemisphere winter months of 2003--2005, 230 infants aged < 24 months hospitalized with ...
Rich, F. J., Pearce, N., Cheng, S., Cunningham, CW, Kirman, JR, Cheng, S, Pearce, N, Grimwood, K., Cohet, C., Wood, C, Redshaw, N, Wood, C., Cunningham, C. W., Grimwood, K, Rich, FJ, Cohet, C, Redshaw, N., Kirman, J. R.   +17 more
core   +1 more source

Identification of group B respiratory syncytial viruses that lack the 60-nucleotide duplication after six consecutive epidemics of total BA dominance at coastal Kenya [PDF]

, 2013
Respiratory syncytial virus BA genotype has reportedly replaced other group B genotypes worldwide. We report the observation of three group B viruses, all identical in G sequence but lacking the BA duplication, at a coastal district hospital in Kenya in ...
Agoti, Charles N., Medley, Graham, Cane, Patricia, Nokes, D. James, Gitahi, Caroline W.   +4 more
core   +1 more source

A Confirmatory, Dual Center Nonhuman Primate Study on the Efficacy of Novel Oropharyngeal Spray Immunization With an Adenoviral Vector Vaccine Against RSV-Important Lessons Learned. [PDF]

J Med Primatol
ABSTRACT Background In a randomized, blinded, dual center study across two European primate research facilities, we evaluated the immunogenicity and protective efficacy of a DNA prime—oropharyngeal adenoviral boost vaccination strategy against respiratory syncytial virus (RSV).
Tenbusch M, Koopman G, Mooij P, Roshani B, Irrgang P, Lapuente D, Kondova I, Bogers WM, Remarque EJ, Vestweber R, Merida Ruiz SA, Krüger N, Meyer S, Gefeller O, Stahl-Hennig C, Überla K.   +15 more
europepmc   +2 more sources

Incidence and severity of respiratory syncytial virus pneumonia in rural Kenyan children identified through hospital surveillance [PDF]

, 2009
Background.Although necessary for developing a rationale for vaccination, the burden of severe respiratory syncytial virus (RSV) disease in children in resource‐poor settings remains poorly defined.
Cane, Patricia A, Nokes, D. James, English, M. (Mike), Ngama, Mwanajuma, Scott, J Anthony G, Medley, Graham F, Medley, Graham, Cane, Patricia, English, Mike, Munywoki, Patrick, Bett, Anne, Scott, J. Anthony G., Nokes, D James, Abwao, John   +13 more
core   +1 more source

Defining the timing of respiratory syncytial virus (RSV) outbreaks: an epidemiological study [PDF]

BMC Infectious Diseases, 2005
Abstract Background Seasonal RSV infections occur every year and affect particularly children under six months of age. Passive immunoprophylaxis with monoclonal antibody Palivizumab is recommended in the period with high risk of RSV infection.
Enders Martin, Schalasta Gunnar, Enders Gisela, Terletskaia-Ladwig Elena   +3 more
openaire   +3 more sources